Endophthalmitis caused by intravitreal injection is a rare disease which impair patients’s vision. In recent years, with the increase of the diseases and frequency of intravitreal injections, the incidence of endophthalmitis has increased. Standardizing each step of intravitreal injections is an important method to reduce postoperative endophthalmitis. Despite the current availability of prevention strategies providing by a lot of clinical trials, there are considerable variations and a lack of consensus and inconsistencies in clinical practice. Understanding the existing key measures, standardizing the operation of intravitreal injection in my country, and minimizing the incidence of infective endophthalmitis are of positive significance for improving the treatment of ophthalmology, especially fundus diseases.
Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) is a condition characterized by episodes of apnea and hypopnea during sleep, with sleep snoring being the primary symptom. The association between OSAHS and ophthalmic diseases has long been recognized, and the potential pathogenic mechanisms have been widely investigated in recent years. It is currently believed that the alteration of inflammatory factors caused by OSAHS plays a key role, affecting vascular function and ultimately leading to the occurrence of diseases. Numerous studies have found a close relationship between OSAHS and the development of fundus diseases. Further research into the pathogenesis of OSAHS is needed in the future to enrich the conclusions regarding the relationship between OSAHS and eye diseases, with the aim of achieving prevention, treatment, and favorable prognosis for related eye conditions.